LEVERAGE LONG - BAYER | Market Closed - Swiss Exchange 11:20:00 2024-05-10 EDT | ||
| 0.1 CHF | +11.11% |
|
| Current month | +26.58% | ||
| 1 month | +12.36% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
Latest news about BAYER AG
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.1 | +11.11% | 0 |
| 24-05-07 | 0.09 | +3.45% | 0 |
| 24-05-02 | 0.087 | +10.13% | 0 |
Delayed Quote Swiss Exchange
Last update May 10, 2024 at 11:20 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| B4LASG | |
| ISIN | DE000SB396W4 |
| Date issued | 2020-08-10 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 22.23 CHF |
|---|---|
| Lowest since issue | 0.073 CHF |
| Spread | 0.01 CHF |
| Spread % | 9.09% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.69
EUR
Average target price
36.9
EUR
Spread / Average Target
+28.63%
- Stock Market
- Certificates
- B4LASG Certificat